Atopy Patch Test in Children With Atopic Dermatitis
Launched by MAHIDOL UNIVERSITY · Sep 16, 2015
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
The prevalence of food allergy seems to be increasing, which might explain the increased demand for reliable evaluation of patients with suspected food-related gastrointestinal symptoms. Little is known about the diagnostic accuracy of atopy patch tests(APT) in the clinical practice. APT seems to have a better specificity than the IgE methods and seems to reflect late-phase clinical reactions.The aims of this study were to evaluate:
(i) The prevalence of positive reaction of APTs for atopic dermatitis (ii)Positive reaction of APT compare with skin prick test. (iii)Positive reaction of APT ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who had history of atopic dermatitis
- Exclusion Criteria:
- • Who have dermographism
- • Who have chronic disease eg. autoimmune disease, immune deficiency, cancer or allergic disease
- • Pregnant women
- • Who receive antihistamine, topical steroid and systemic steroid \> 20 mg/day within 7 days prior study
About Mahidol University
Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials